ACR Meeting Abstracts
Abstract Number: 2731 • ACR/ARP Annual Meeting 2019
Natalie McCormick1, Zachary Wallace 2, Chana Sacks 3, John Hsu 4 and Hyon K. Choi 5, 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, 2Massachusetts General Hospital, Boston, 3Department of General Internal Medicine, Massachusetts General Hospital; Department of Medicine, Harvard Medical School, Boston, MA, 4Mongan Institute, Massachusetts General Hospital; Department of Health Care Policy, Harvard Medical School, Boston, MA, 5Massachusetts General Hospital, Boston, MA
Background/Purpose: Billions of public dollars are spent each year on biologic disease-modifying anti-rheumatic drugs (bDMARDs), but the drivers of bDMARD spending and per-patient cost increases…